141 related articles for article (PubMed ID: 7768199)
1. Comparative cardiac effects of milrinone and sodium nitroprusside in conscious rats.
Desjardins S; Cauchy MJ
Drug Chem Toxicol; 1995 Feb; 18(1):43-59. PubMed ID: 7768199
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of milrinone on the electrocardiogram and the cardiac hemodynamics of rats with pressure overload-induced congestive heart failure.
Desjardins S; Cauchy MJ
Arch Int Pharmacodyn Ther; 1989; 301():182-99. PubMed ID: 2624514
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
5. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
6. Myocardial and vascular actions of milrinone.
Colucci WS
Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
[TBL] [Abstract][Full Text] [Related]
7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
8. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue AS
Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
[TBL] [Abstract][Full Text] [Related]
9. Species-dependent pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005.
Dundore RL; Pagani ED; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1995 Jan; 25(1):14-21. PubMed ID: 7723343
[TBL] [Abstract][Full Text] [Related]
10. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
11. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease.
Borow KM; Come PC; Neumann A; Baim DS; Braunwald E; Grossman W
Am J Cardiol; 1985 Apr; 55(9):1204-9. PubMed ID: 3984901
[TBL] [Abstract][Full Text] [Related]
12. Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Gerard JL; Berdeaux A; Giudicelli JF
Eur J Pharmacol; 1989 Jun; 165(1):39-49. PubMed ID: 2767134
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.
Dorszewski A; Müller-Beckmann B; Kling L; Sponer G
Br J Pharmacol; 1990 Nov; 101(3):686-90. PubMed ID: 2076485
[TBL] [Abstract][Full Text] [Related]
14. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
15. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Katano Y; Endoh M
J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
[TBL] [Abstract][Full Text] [Related]
16. Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
Lynch JJ; Uprichard AC; Frye JW; Driscoll EM; Kitzen JM; Lucchesi BR
J Cardiovasc Pharmacol; 1989 Oct; 14(4):585-97. PubMed ID: 2478772
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Wilhelm D; Wilffert B; Janssens WJ; Leidig A; Meuter C; Ebbert M; Peters T
J Cardiovasc Pharmacol; 1992; 20(5):705-14. PubMed ID: 1280731
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
Holbrook M; Coker SJ
Br J Pharmacol; 1989 Sep; 98(1):318-24. PubMed ID: 2478245
[TBL] [Abstract][Full Text] [Related]
19. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
Young RA; Ward A
Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients.
Prielipp RC; MacGregor DA; Butterworth JF; Meredith JW; Levy JH; Wood KE; Coursin DB
Chest; 1996 May; 109(5):1291-301. PubMed ID: 8625682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
